1. W. Park, T. Flaig, X. Yang, L.-J. Su and K. Emoto, “Multifunctional nanomaterials for treatment of cancer”, United States Patent 10,052,393 (Aug. 21, 2018).
  2. S. K. Cho, L.-J. Su, C. Mao, C. D. Wolenski, T. W. Flaig, W. Park, "Multifunctional nanoclusters of NaYF4:Yb3+,Er3+ upconversion nanoparticle and gold nanorod for simultaneous imaging and targeted chemotherapy of bladder cancer", Mater. Sci. Eng. C  9, 784-792 (2019). 
  3. M. Brasino, S. Roy, A. Erbse, L. He, C. Mao, W. Park, J. Cha and A. Goodwin, “Anti-EGFR Affibodies with Site-Specific Photocrosslinker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors”, J. Am. Chem. Soc. 140, 11820–11828 (2018).
  4. X. Yang, L.-J. Su, F. G. La Rosa, E. E. Smith, I. R. Schlaepfer, S. K. Cho, B. Kavanagh, W. Park and T. W. Flaig, “The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model”, Bladder Cancer 3, 201-210 (2017).
  5. L. He, J. Dragavon, S. Cho, C. Mao, A. Yildirim, K. Ma, R. Chattaraj, A. P. Goodwin, W. Park, J. N. Cha, “Self-Assembled Gold Nanostar-NaYF4:Yb/Er Clusters for Multimodal Imaging, Photothermal and Photodynamic Therapy”, J. Mater. Chem. B 4, 4455-4461 (2016).
  6. S. K. Cho, K. Emoto, L.-J. Su, X. Yang, T. W. Flaig and W. Park, “Functionalized gold nanorods for thermal ablation treatment of bladder cancer”, J. Biomed. Nanotechnol. 10, 1267-1276 (2014)